Tag: IMpassion130

Contradicting results for chemoimmunotherapy in metastatic TNBC

Conference
ESMO 2020
Type
Peer-reviewed article

25 November 2020 16:01

No higher pathologic complete response with atezolizumab added to chemotherapy

Trial
IMpassion130
Conference
SABCS 2019
Type
Peer-reviewed article

13 February 2020 23:54

ImPassion130 brings breast cancer into the immunotherapy era

Trial
Phase 3, ImPassion130
Conference
ASCO 2019
Type
Peer-reviewed article

15 July 2019 11:27
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com